Fulcrum Therapeutics Inc. (FULC)
FULC trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$3.68
-1.87% on the day
Market cap
$281.1M
Micro cap
Revenue · 2025
$0
No prior year to compare
Net income · 2025
-$74.9M
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), period ending 2025-12-31, https://www.sec.gov/Archives/edgar/data/1680581/000119312526065197/0001193125-26-065197-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), period ending 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | FULC on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2019 |
| SEC CIK | 0001680581 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $0 |
| Net income | -$74.9M |
| Operating income | -$84.8M |
| Net margin | Needs revenue and net income |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | $197.5M |
| Total assets | $366.3M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | Needs market cap and revenue |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2025-12-11 |
| Latest annual report | 10-K | 2026-02-24 |
| Latest quarterly / interim | 10-Q | 2026-07-30 |
| Latest current report | 8-K | 2026-08-17 |
| Latest proxy | DEFA14A | 2026-04-30 |
Source: SEC EDGAR submissions feed, 514 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| PRLD | Prelude Therapeutics Incorporated | $3.56 | -4.81% | $284.1M |
| BNTC | Benitec Biopharma Inc. | $8.63 | -4.85% | $301.0M |
| VNDA | Vanda Pharmaceuticals Inc. | $4.30 | -5.29% | $260.0M |
| CATX | Perspective Therapeutics Inc. | $2.27 | -9.92% | $259.1M |
| ABEO | Abeona Therapeutics Inc. | $4.52 | -7.75% | $258.5M |
| CYPH | Cypherpunk Technologies Inc. | $2.84 | -2.07% | $306.1M |
| BIOA | BioAge Labs Inc. | $5.57 | -6.23% | $255.6M |
| BCYC | Bicycle Therapeutics plc | $3.63 | -4.47% | $254.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier